Expert Interviews

Anila Chadha, MD, highlights key preventive strategies to reduce CVD risk in patients with obesity and how to tailor them to address individual patient needs.

More than 6 in 10 adults treated with the investigational CRF1 antagonist crinecerfont reached a physiologic glucocorticoid dose with androstenedione control maintained.

Dr Richard Auchus says the ideal treatment for congenital adrenal hyperplasia is a long way off but describes a "block and replace" strategy that holds great promise.

Crinecerfont, a CRF1 antagonist, could help reduce glucocorticoid doses for individuals with CAH and improve physical and emotional quality of life, says leading researcher.

The approval of neffy (epinephrine nasal spray) could help individuals and caregivers act sooner and feel safer treating a type 1 allergic reaction.

Steven Furr, MD, discusses how communication between clinicians and patients is crucial to combatting vaccine hesitancy this upcoming respiratory virus season.

Richard J Auchus, MD, PhD, a preeminent steroid biologist, provides a concise and thorough primer on CAH and the challenges in managing the disorder safely and effectively.

The medical experts conclude by summarizing essential insights and practical tips for effectively managing diabetes in elderly patients.

Medical professionals evaluate strategies for optimizing diabetes treatment protocols in older adults, emphasizing the critical role of deprescribing in geriatric diabetes care.

Diabetes specialists examine the shifting paradigm of type 2 diabetes treatment, highlighting the role of combination therapies and emerging approaches specifically designed for geriatric patients.

The panel examines crucial factors in determining appropriate medication dosages and managing glucose levels for elderly patients with type 2 diabetes.

Medical experts analyze a case involving a 78-year-old man with a 15-year history of Type 2 Diabetes Mellitus.

A panel of medical experts presents a case study featuring a 68-year-old woman exhibiting classic diabetes symptoms—polyuria, polydipsia, and significant weight loss—along with a notably elevated glucose level of 458 mg/dL.

Medical doctors examine strategies for customizing diabetes care for older adults across various environments, from home settings to healthcare facilities.

Medical experts explore personalized diabetes management strategies, emphasizing the critical need to tailor treatments for older adults.

The panel concludes its discussion with key takeaways on the optimal care of patients with type 1 diabetes care and thoughts on unmet needs within the treatment space.

Focusing on logistical matters as it pertains to teplizumab administration, the panel discusses infusion site considerations, insurance coverage hurdles, and the process of getting patients approved.

Diabetes specialists outline the patient selection protocol for teplizumab and describe the teplizumab infusion process.

Experts on type 1 diabetes discuss the availability of local medical facilities that offer teplizumab screening and evaluation services for individuals at risk of progression of disease.

Amy Burton, MD, reviews findings from the TN-10 study investigating teplizumab, an anti-CD3 monoclonal antibody, for prevention of diabetes in relatives at risk for T1D.

Diabetes experts discuss the important role of teplizumab in delaying the onset of type 1 diabetes and provide insights on the drug’s mechanism of action.

Following audience polls, the panelists provide clinical insights into their screening practices for patients with type 1 diabetes, highlighting key antibodies they screen for.

Audience polls provide the panel insights into common screening practices for patients with type 1 diabetes.

The panel outlines the stages of type 1 diabetes, focusing on the importance of early intervention to prevent complications of the disease.

A panel of experts on type 1 diabetes (T1D) describe the prevalence and burden of the disease, highlighting the emotional and socio-economic burden extending beyond medical expenses.

Encouraging patients to reach out with questions may lead more to roll up their sleeves this season, Tochi Iroku-Malize, MD, told Patient Care.

The expert panel concludes by analyzing a patient case and offering final insights on customizing treatment for complex geriatric diabetes patients, taking into account cardiovascular health, weight management, and renal function considerations.

Key opinion leaders explore methods for optimizing treatment in older adults with type 2 diabetes, focusing on streamlining regimens and the process of deprescribing, with particular emphasis on defining and implementing the deprescribing approach.

Experts examine strategies for managing treatment modifications in older adults with type 2 diabetes, weighing the approaches, challenges, and advantages of combination therapy regimens.

Leading experts in geriatric diabetes care explore comprehensive aspects of insulin therapy, including dosing strategies, available injectable options, and methods for tailoring glucose control in elderly patients.